PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 207 filers reported holding PTC THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,076,580 | -17.9% | 174,000 | -2.2% | 0.88% | -49.6% |
Q1 2023 | $8,622,320 | +125.9% | 178,000 | +78.0% | 1.74% | +116.9% |
Q4 2022 | $3,817,000 | -53.4% | 100,000 | -38.7% | 0.80% | -49.6% |
Q3 2022 | $8,183,000 | +95.2% | 163,000 | +55.7% | 1.59% | +84.5% |
Q2 2022 | $4,193,000 | +167.6% | 104,656 | +149.2% | 0.86% | +111.3% |
Q1 2022 | $1,567,000 | -12.6% | 42,000 | -6.7% | 0.41% | -17.7% |
Q4 2021 | $1,792,000 | -50.4% | 45,000 | -53.7% | 0.50% | -52.3% |
Q3 2021 | $3,613,000 | -22.4% | 97,100 | -11.8% | 1.04% | -18.9% |
Q2 2021 | $4,654,000 | -1.8% | 110,100 | +10.0% | 1.28% | -5.4% |
Q1 2021 | $4,740,000 | +158.0% | 100,100 | +232.6% | 1.35% | +148.0% |
Q4 2020 | $1,837,000 | +30.6% | 30,100 | 0.0% | 0.55% | +27.0% |
Q3 2020 | $1,407,000 | -7.6% | 30,100 | +0.3% | 0.43% | -5.7% |
Q2 2020 | $1,522,000 | – | 30,000 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |